Coherus raises $100M in note deal

Biosimilar developer Coherus BioSciences Inc. (NASDAQ:CHRS) raised $100 million in a private placement of senior convertible notes. New investor HealthCare Royalty Partners purchased $75 million of the notes and existing investor KKR contributed $20 million. Founding investors MX II and KMG also participated. ...